Newsletter - June 28, 2019
RWE for Diversity in Clinical Data
Most clinical trials struggle to recruit diverse populations. Use of Real World Evidence (RWE) may offer the solution to this problem. Despite active encouragement and a few guidance documents from FDA about the importance of diversity in clinical trial populations...Read More
Is India a New Destination for Medical AI Development?
A prominent blog this week speculated why India seems to be becoming an attractive place for developers of Artificial Intelligence (AI) based medical technology. India offers some obvious advantages to developers over other countries in the region, however...Read More
RWE for Diversity in Clinical Data
Most clinical trials struggle to recruit diverse populations. Use of Real World Evidence (RWE) may offer the solution to this problem. Despite active encouragement and a few guidance documents from FDA about the importance of diversity in clinical trial populations...Read More
Is India a New Destination for Medical AI Development?
A prominent blog this week speculated why India seems to be becoming an attractive place for developers of Artificial Intelligence (AI) based medical technology. India offers some obvious advantages to developers over other countries in the region, however...Read More
